Advertisements

Stocking Stuffers

 

IntelGenx Technologies Corp. (IGX:CA) Stock Quote

Detailed Quote for IntelGenx Technologies Corp. (IGX:CA)
$ 0.88   0.01 (+1.15%) Volume: 22.15k 3:46 PM EDT 22-Mar-2019
Today 5d 1m 3m 1y more
Last Price
0.88
Change $
0.01
Change %
1.15%
Tick
  
Bid
0.84
Bid Size
5,500
Ask
0.90
Ask Size
4,500
Open
0.84
High
0.88
Low
0.84
Prev Close
0.87
Last Trade
03/22/19
Volume
22.15k
52 Wk Hi
2.35999989
52 Wk Low
0.620000004
Market Cap
82.3m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
93,527,474
EPS (TTM)
-0.170000001
PE Ratio
N/A
Exchange
TSXV
News and Media for IntelGenx Technologies Corp. (IGX:CA)
Sector News | Topic News
News for IntelGenx Technologies Corp. (IGX:CA)
Fri, Mar 22, 2019
4:05 PM IntelGenx Reports Fourth Quarter and Full-Year 2018 Financial Results - GlobeNewswire
Mon, Mar 18, 2019
5:35 PM CORRECTION - IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 22, 2019 - Conference Call to Follow on March 25, 2019 - GlobeNewswire
4:00 PM IntelGenx to Report Fourth Quarter and Full-Year 2018 Financial Results on March 25, 2019 - Conference Call to Follow - GlobeNewswire
Thu, Feb 14, 2019
8:00 AM IntelGenx Announces Montreal's Douglas Mental Health University Institute as Ninth Montelukast VersaFilm(TM) Phase 2a Clinical Trial Site - GlobeNewswire
Mon, Feb 11, 2019
8:00 AM IntelGenx Granted Japanese Patent for RIZAPORT\u00AE VersaFilm(TM) - GlobeNewswire
Thu, Feb 07, 2019
4:00 PM IntelGenx Strengthens Senior Management Team - GlobeNewswire
Wed, Jan 30, 2019
8:00 AM IntelGenx Facility Undergoes U.S. FDA Pre-Approval Inspection Related to RIZAPORT\u00AE NDA - GlobeNewswire
Wed, Jan 23, 2019
8:00 AM IntelGenx Provides Update on Phase 2a Montelukast VersaFilm(TM) Clinical Trial - GlobeNewswire
Mon, Jan 14, 2019
8:00 AM IntelGenx Provides Update on Cannabis-Infused VersaFilm(TM) Program Following Recently Proposed Amendments to the Cannabis Act - GlobeNewswire
Wed, Jan 09, 2019
7:45 AM Today's Research Reports on DIRTT Environmental Solutions, Pioneering Technology, IntelGenx Technologies and Columbus Gold - ACCESSWIRE IA
Wed, Dec 26, 2018
4:00 PM IntelGenx Grants Restricted Share Units - GlobeNewswire
Wed, Dec 12, 2018
8:00 AM IntelGenx Partners with Gensco\u00AE Pharma to Market RIZAPORT\u00AE in the United States - GlobeNewswire
Wed, Dec 05, 2018
4:54 PM IntelGenx Reports Amendment of Stock Option Plan - GlobeNewswire
Fri, Nov 30, 2018
8:00 AM IntelGenx Engages Focus Communications for Investor Relations Program - GlobeNewswire
Tue, Nov 27, 2018
8:00 AM IntelGenx Begins Montelukast VersaFilm(TM) Dosing in Patients with Mild to Moderate Alzheimer's Disease in Phase 2a Study - GlobeNewswire
Tue, Nov 20, 2018
8:00 AM IntelGenx Announces FDA's Acceptance of Resubmission of New Drug Application for RIZAPORT\u00AE - GlobeNewswire
Tue, Nov 13, 2018
4:00 PM IntelGenx Closes Private Placement Financing - GlobeNewswire
7:50 AM Today's Research Reports on IntelGenx Technologies, Titanium, dynaCERT and Copper Mountain Mining - ACCESSWIRE IA
Thu, Nov 08, 2018
4:00 PM IntelGenx Reports Third Quarter 2018 Financial Results - GlobeNewswire
Wed, Nov 07, 2018
8:00 AM IntelGenx Announces Definitive Agreement with Tilray\u00AE to Form an Exclusive, Worldwide Partnership for Cannabis-Infused VersaFilm(TM) Products - GlobeNewswire
More News for IGX:CA >>

Tags for IntelGenx Technologies Corp.

Research stocks or mutual funds related to IntelGenx Technologies Corp. by keywords or tags. Find companies that have a similar focus to IGX:CA. The keywords below have been associated to IGX:CA by either user submission or electronic means.

Diversified Services Research and Development in the Physical, Engineering, and Life Sciences (541710) Services Common Stock Other Scientific and Technical Services (7759)